HOOK Total Utang marang Modal HOOKIPA Pharma
HOOKIPA Pharma Inc. (HOOK) is mitigating financial risks through partnerships with industry behemoths and by diversifying its development pipeline between oncology and vaccines. The price action of the total debt-to-equity ratio, which stands at 0.00, confirms the current liability structure. The business focuses on creating T-cell activators to combat HPV tumors, utilizing automated software to analyze clinical trial big data.
Rincian analitis lan laporan data perusahaan HOOKIPA Pharma (HOOK)
- rega lan prakiraan konsensus rega:
- data kapitalisasi pasar:
- data kapitalisasi buku:
- data utang lan likuiditas:
Utang marang Ekuitas HOOKIPA Pharma Inc.|HOOK - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal HOOKIPA Pharma, Inc.|HOOK - Gunggung utang perusahaan|Utang marang nilai buku HOOKIPA Pharma|HOOK - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan HOOKIPA Pharma
Analisis komprehensif perusahaan:HOOK - HOOKIPA Pharma Inc.
For arenavirus vector innovator HOOKIPA Pharma Inc. (HOOK), the total debt-to-equity ratio serves as an indicator of the balance between debt financing and shareholder equity. This ratio measures the business's degree of financial autonomy, where a rising curve signals liquidity risks, while undervalued figures suggest an suboptimal use of leverage to accelerate the development of anti-cancer drugs.
Pesaing utama
Utang marang Ekuitas argenx ARGX|Utang Agregat marang Ekuitas BioNTech Inc.|Abivax SA (ABVX) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi ADMA Corp (ADMA)|Total Utang marang Modal PTGX (Protagonist Therapeutics)|immunovant.com - Total Utang marang Modal|Utang marang Ekuitas Kiniksa (KNSA)|GRFS: Rasio Kabeh Utang marang Dana Pribadi|ADPT (Adaptive Biotechnologies Corp) - Utang marang Ekuitas|Celldex Corp (CLDX) - Rasio Total Utang marang Ekuitas|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com (BCRX)|Vera Therapeutics (VERA) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Dianthus Therapeutics Inc (DNTH)|Total Utang marang Modal PHVS|AbCellera - Koefisien Total Utang marang Modal|TRML: Utang marang Ekuitas|PGEN: Rasio Total Utang marang Ekuitas|PHAR (Pharming Group) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ZBIO|Utang marang Ekuitas Immunome, Inc. IMNM|Rasio Utang marang Ekuitas gossamerbio.com (GOSS)|KALV: Total Utang marang Modal|Utang marang Modal Septerna, Inc. SEPN|Total Utang marang Modal Pieris Pharmaceuticals Inc (PVLA)|SVRA: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas RIGL|ANAB (anaptysbio.com) - Utang marang Modal|Utang marang Ekuitas ATXS (Astria Therapeutics, Inc.)|Utang marang Modal ENGN|Utang marang Ekuitas RAPT|Total Utang marang Modal aerovatetx.com (JBIO)|Total Utang marang Modal ACRS|kyvernatx.com - Koefisien Total Utang marang Modal|Utang marang Ekuitas Tiziana Life Sciences Ltd|CABA - Utang Agregat marang Ekuitas|VTYX: Total Utang marang Modal|Total Utang marang Modal Theratechnologies, Inc|AVTX - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ELDN|AGEN - Utang marang Ekuitas|Utang Agregat marang Ekuitas Climb Bio Inc. (CLYM)|Total Utang marang Modal Zura Bio Limited|Rasio Kabeh Utang marang Dana Pribadi aTyr Pharmaceuticals ATYR|Adagene Corp - Total Utang marang Modal|IMA: Total Utang marang Modal|Utang marang Ekuitas shattucklabs.com STTK|EQ (Equillium) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas CNTB|Rasio Total Utang marang Ekuitas Immunic Inc|Total Utang marang Modal ATRA|Total Utang marang Modal inflarx.de IFRX|Rasio Total Utang marang Ekuitas X4 Pharmaceuticals, Inc.|Rasio Kabeh Utang marang Dana Pribadi Adicet Bio Inc. ACET|Total Utang marang Modal CELU (Celularity Corp)|INMB: Koefisien Total Utang marang Modal|Utang marang Ekuitas Barinthus Biotherapeutics|kezarlifesciences.com (KZR) - Rasio Utang marang Ekuitas|Total Utang marang Modal SABS|Rasio Total Utang marang Ekuitas Akari Therapeutics PLC (AKTX)|ENLV (Enlivex Therapeutics) - Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal q32bio.com (QTTB)|Total Utang marang Modal GeoVax Labs, Inc.|edesabiotech.com - Rasio Kabeh Utang marang Dana Pribadi|IBIO (iBio) - Utang marang Ekuitas|CARM: Utang marang Modal|Utang marang Ekuitas XTLB|BOLT (Bolt Biotherapeutics, Inc.) - Utang marang Modal|HCWB (HCW Biologics, Inc.) - Utang marang Ekuitas|Total Utang marang Modal APVO|AIM - Utang marang Ekuitas|Utang Agregat marang Ekuitas aditxt.com (ADTX)|Total Utang marang Modal GRI Bio Corp|Rasio Kabeh Utang marang Dana Pribadi XORTX Corp XRTX|Vyome Holdings Inc - Total Utang marang Modal|REVB: Total Utang marang Modal|Utang marang Ekuitas Indaptus Therapeutics, Inc. INDP|SCNI (Scinai Immunotherapeutics Ltd) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas CALI|Rasio Total Utang marang Ekuitas Affimed Therapeutics|Total Utang marang Modal ALLK|Total Utang marang Modal igmbio.com IGMS|Rasio Total Utang marang Ekuitas iTeos Therapeutics, Inc.|Rasio Kabeh Utang marang Dana Pribadi Ocean Biomedical Inc OCEA|Total Utang marang Modal TCBP (TC BioPharm (Holdings) PLC)|THRD: Koefisien Total Utang marang Modal